Log in to save to my catalogue

State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis

State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2158401977

State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis

About this item

Full title

State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis

Publisher

Cham: Elsevier Inc

Journal title

Journal of nuclear cardiology, 2019-02, Vol.26 (1), p.158-173

Language

English

Formats

Publication information

Publisher

Cham: Elsevier Inc

More information

Scope and Contents

Contents

Cardiac amyloidosis, once considered untreatable, is now gaining well-deserved attention due to advances in imaging and the recent approval of targeted breakthrough therapies. In this paper, we discuss the role of radionuclide imaging in the evaluation and management of patients with the most common form of amyloidosis—cardiac transthyretin amyloid...

Alternative Titles

Full title

State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2158401977

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2158401977

Other Identifiers

ISSN

1071-3581,1532-6551

E-ISSN

1532-6551

DOI

10.1007/s12350-018-01552-4

How to access this item